Correlation Between Eterna Therapeutics and Scholar Rock

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eterna Therapeutics and Scholar Rock at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eterna Therapeutics and Scholar Rock into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eterna Therapeutics and Scholar Rock Holding, you can compare the effects of market volatilities on Eterna Therapeutics and Scholar Rock and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eterna Therapeutics with a short position of Scholar Rock. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eterna Therapeutics and Scholar Rock.

Diversification Opportunities for Eterna Therapeutics and Scholar Rock

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Eterna and Scholar is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and Scholar Rock Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scholar Rock Holding and Eterna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eterna Therapeutics are associated (or correlated) with Scholar Rock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scholar Rock Holding has no effect on the direction of Eterna Therapeutics i.e., Eterna Therapeutics and Scholar Rock go up and down completely randomly.

Pair Corralation between Eterna Therapeutics and Scholar Rock

Given the investment horizon of 90 days Eterna Therapeutics is expected to under-perform the Scholar Rock. In addition to that, Eterna Therapeutics is 1.28 times more volatile than Scholar Rock Holding. It trades about -0.49 of its total potential returns per unit of risk. Scholar Rock Holding is currently generating about 0.38 per unit of volatility. If you would invest  2,638  in Scholar Rock Holding on September 18, 2024 and sell it today you would earn a total of  1,705  from holding Scholar Rock Holding or generate 64.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Eterna Therapeutics  vs.  Scholar Rock Holding

 Performance 
       Timeline  
Eterna Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eterna Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Scholar Rock Holding 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Scholar Rock Holding are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite inconsistent basic indicators, Scholar Rock disclosed solid returns over the last few months and may actually be approaching a breakup point.

Eterna Therapeutics and Scholar Rock Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eterna Therapeutics and Scholar Rock

The main advantage of trading using opposite Eterna Therapeutics and Scholar Rock positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eterna Therapeutics position performs unexpectedly, Scholar Rock can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scholar Rock will offset losses from the drop in Scholar Rock's long position.
The idea behind Eterna Therapeutics and Scholar Rock Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets